DYNAMICS OF THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHF ON THE BACKGROUND OF CORONOVIRUS INFECTION
Main Article Content
Abstract
Chronic heart failure (CHF) retains a leading position among all causes of cardiovascular mortality, especially in such a difficult period as the coronavirus pandemic. It is important that heart failure is much more severe in patients with COVID-19 than in people without this disease, which is one of the most common causes that increases the risk of mortality in SARS-CoV-2 infection. Although the WHO announced the end of the COVID-19 pandemic this spring, it cannot be denied that the SARS-CoV-2 virus, including its various strains, has not disappeared anywhere and still poses a serious threat to the health system around the world.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Bubnova M.G., Aronov D.M. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation // Pulmonology. — 2020. — Т. 30, № 5. — С. 688–699.
Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–260.
Shi S., Qin M., Shen B. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5: 802. Doi: 10.1001/jamacardio.2020.0950.
Kim A.H.J., Sparks J.A., Liew J.W. Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med. 2020;172:819–821.
Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020; 76: 533–546.